MARIA RIZZO: Open Payments
NPI 1689825929 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 9 payments from 7 companies in 2025. Trend: 2023 $1,048 · 2024 $1,303 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 2 | $66 |
| PFIZER INC. | 2 | $35 |
| Eisai Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $22 |
| Biogen, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: Xeomin, NURTEC ODT, Leqembi, REXULTI, SKYCLARYS, AUSTEDO XR, INGREZZA.
Industry payments across NY — which companies pay providers there.
